Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 8, 2010, Pages 838-849

  Shu, Hai Feng ^a   Zhang, Chun Qing ^a   Yin, Qing ^a   An, Ning ^a   Liu, Shi Yong ^a   Yang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Focal cortical dysplasia; Interleukin 6; Malformations of cortical development; Tuberous sclerosis complex.

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE 2; MESSENGER RNA; STAT PROTEIN; STAT3 PROTEIN;

ARTICLE; ASTROCYTE; BRAIN CORTEX LESION; CELL LABELING; CELL LINEAGE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; FEMALE; GIANT NERVE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; NERVE CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

CELL COUNT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; CYTOKINE RECEPTOR GP130; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; INTERLEUKIN-6; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; NERVE TISSUE PROTEINS; RECEPTORS, INTERLEUKIN-6; TUBEROUS SCLEROSIS;

EID: 77955473757     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181eaeae5     Document Type: Article

References (40)

1. Crino PB. Focal brain malformations: Seizures, signaling, sequencing. Epilepsia 2009;50(suppl 9):3-8
2. Barkovich AJ, Kuzniecky RI, Jackson GD, et al. A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-1887
3. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62:S2-8
4. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-1356
5. Becker AJ, Blumcke I, Urbach H, et al. Molecular neuropathology of epilepsy-associated glioneuronal malformations. J Neuropath Exp Neurol 2006;65:99-108
6. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008;49:8-21
7. Lamparello P, Baybis M, Pollard J, et al. Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain 2007;130:2267-2276
8. Blumcke I, Vinters HV, Armstrong D, et al. Malformations of cortical development and epilepsies: Neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009;11:181-193
9. Schick V, Majores M, Engels G, et al. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells. Brain Pathol 2007;17:165-173
10. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803
11. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsyassociated malformations of cortical development. Neurobiol Dis 2006; 24:128-143
12. Fukuda M, Suzuki Y, Ishizaki Y, et al. Interleukin-1beta enhances susceptibility to hyperthermia-induced seizures in developing rats. Seizure 2009;18:211-214
13. Rijkers K, Majoie HJ, Hoogland G, et al. The role of interleukin-1 in seizures and epilepsy: A critical review. Exp Neurol 2009;216:258-271
14. Boer K, Jansen F, Nellist M, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 2008;78:7-21
15. Boulanger MJ, Chow DC, Brevnova EE, et al. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 2003;300:2101-2104
16. Peters M,Muller AM, Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis. Blood 1998;92: 3495-3504
17. Tenhumberg S, Waetzig GH, Chalaris A, et al. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. J Biol Chem 2008;283:27200-27207
18. Rose-John S, Neurath MF. IL-6 trans-signaling: The heat is on. Immunity 2004;20:2-4
19. Juttler E, Tarabin V, Schwaninger M. Interleukin-6 (IL-6): A possible neuromodulator induced by neuronal activity. Neuroscientist 2002;8: 268-275
20. Lehtimaki KA, Keranen T, Huhtala H, et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: The effect of seizure type and duration. J Neuroimmunol 2004;152:121-125
21. Sallmann S, Juttler E, Prinz S, et al. Induction of interleukin-6 by depolarization of neurons. J Neurosci 2000;20:8637-8642
22. Engel J, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In: Engel J, ed. Surgical Treatment of the Epilepsies. New York, NY: Raven Press, 1993:609-621
23. Gomez M, Sampson J, Whittemore V. The Tuberous Sclerosis Complex. Oxford, UK: Oxford University Press, 1999
24. Harting MT, Jimenez F, Adams SD, et al. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 2008;144:803-813
25. Toering ST, Boer K, de Groot M, et al. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 2009;50:1409-1418
26. Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev 2001;23:508-515
27. Heinrich PC, Behrmann I, Muller-Newen G, et al. Interleukin-6Ytype cytokine signalling through the gp130/JAK/STAT pathway. Biochem J 1998;334:297-314
28. Giacomini D, Acuna M, Gerez J, et al. Pituitary action of cytokines: Focus on BMP-4 and gp130 family. Neuroendocrinology 2007;85:94-100
29. De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12:2623-2633
30. Peltola J, Palmio J, Korhonen L, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonicclonic seizures. Epilepsy Res 2000;41:205-211
31. Kirkman NJ, Libbey JE, Wilcox KS, et al. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 2010;51:454-464
32. Wang Y, Greenwood JS, Calcagnotto ME, et al. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 2007;61:139-152
33. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-235
34. de Araujo EG, da Silva GM, Dos Santos AA. Neuronal cell survival: The role of interleukins. Ann NY Acad Sci 2009;1153:57-64
35. Xiao E, Xia L, Ferin M, et al. Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate. J Neuroimmunol 1999;97:70-76
36. Choi JS, Kim SY, Park HJ, et al. Upregulation of gp130 and differential activation of STAT and p42/44 MAPK in the rat hippocampus following kainic acidYinduced seizures. Brain Res 2003;119:10-18
37. Skiniotis G, Lupardus PJ, Martick M, et al. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol Cell 2008;31:737-748
38. Yoshida K, Taga T, Saito M, et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci\USA 1996;93:407-411
39. Kalueff AV, Lehtimaki KA, Ylinen A, et al. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci Lett 2004;365:106-110
40. Campbell IL, Abraham CR, Masliah E, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci\USA 1993;90:10061-65